A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study
- 1 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S285
- https://doi.org/10.1016/s0959-8049(01)81543-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: